Gyre Therapeutics, Inc. GYRE Gyre Pharmaceuticals — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre pharmaceuticals — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre pharmaceuticals — total assets?
- Gyre Therapeutics, Inc. (GYRE) reported gyre pharmaceuticals — total assets of $137.35M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s gyre pharmaceuticals — total assets changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre pharmaceuticals — total assets increased by 12.3% year-over-year, from $122.35M to $137.35M.
- What does gyre pharmaceuticals — total assets mean?
- This represents the total economic resources controlled by the business segment that are expected to provide future benefits. It includes tangible and intangible assets specifically utilized or held by this segment. This metric is essential for evaluating the capital intensity and asset utilization efficiency of the segment.